MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights
May 12, 2015 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - May 12, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Initiates Clinical Study on Fortetropin(R) Dose Response
May 11, 2015 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - May 11, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Announces the Re Muscle Health(TM) Series Powered by Fortetropin(R)
March 30, 2015 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 30, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights
March 27, 2015 16:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 27, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference
February 23, 2015 07:30 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 23, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Research Selected to Be Presented at International Conference on Molecular and Cellular Biology
February 11, 2015 08:05 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 11, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation's Preclinical Study of Fortetropin's(TM) Mechanism of Action Demonstrate Regulatory Effects on Three Key Muscle Health Pathways
January 22, 2015 08:00 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jan 22, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present at the Eighth Annual OneMedForum Conference on January 13, 2015
January 07, 2015 07:05 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jan 7, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces $1.81 Million Registered Direct Offering
November 18, 2014 09:25 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 18, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update
November 14, 2014 10:30 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...